146 related articles for article (PubMed ID: 11354286)
1. Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines.
Shiraga K; Sakaguchi K; Senoh T; Ohta T; Ogawa S; Sawayama T; Mouri H; Fujiwara A; Tsuji T
J Gastroenterol Hepatol; 2001 Apr; 16(4):460-6. PubMed ID: 11354286
[TBL] [Abstract][Full Text] [Related]
2. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
[TBL] [Abstract][Full Text] [Related]
3. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
[TBL] [Abstract][Full Text] [Related]
4. Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells.
Pang E; Hu Y; Chan KY; Lai PB; Squire JA; Macgregor PF; Beheshti B; Albert M; Leung TW; Wong N
Lab Invest; 2005 May; 85(5):664-74. PubMed ID: 15765123
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
6. Drug concentration-dependent expression of multidrug resistance-associated protein and P-glycoprotein in the doxorubicin-resistant acute myelogenous leukemia sublines.
Choi CH; Kim HS; Rha HS; Jeong JH; Park YH; Min YD; Kee KH; Lim DY
Mol Cells; 1999 Jun; 9(3):314-9. PubMed ID: 10420992
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.
Tong AW; Su D; Mues G; Tillery GW; Goldstein R; Klintmalm G; Stone MJ
Clin Cancer Res; 1996 Mar; 2(3):531-9. PubMed ID: 9816200
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm.
Ding L; Chen XP; Zhang ZW; Guan J; Zhang WG; Wang HP; Wang ZH; Li CL
World J Gastroenterol; 2005 Sep; 11(36):5621-6. PubMed ID: 16237754
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells.
Ling X; Zhou Y; Li SW; Yan B; Wen L
Int J Biol Sci; 2010 Dec; 6(7):773-83. PubMed ID: 21152118
[TBL] [Abstract][Full Text] [Related]
10. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
11. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
[TBL] [Abstract][Full Text] [Related]
12. Chebulagic acid synergizes the cytotoxicity of doxorubicin in human hepatocellular carcinoma through COX-2 dependant modulation of MDR-1.
Achari C; Reddy GV; Reddy TC; Reddanna P
Med Chem; 2011 Sep; 7(5):432-42. PubMed ID: 21801152
[TBL] [Abstract][Full Text] [Related]
13. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a human hepatoma multidrug resistant cell line in vitro.
Zhou Y; Ling XL; Li SW; Li XQ; Yan B
World J Gastroenterol; 2010 May; 16(18):2291-7. PubMed ID: 20458768
[TBL] [Abstract][Full Text] [Related]
15. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
[TBL] [Abstract][Full Text] [Related]
16. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression.
Carabias P; Espelt MV; Bacigalupo ML; Rojas P; Sarrias L; Rubin A; Saffioti NA; Elola MT; Rossi JP; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF
Cell Death Dis; 2022 Jan; 13(1):79. PubMed ID: 35075112
[TBL] [Abstract][Full Text] [Related]
19. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
[TBL] [Abstract][Full Text] [Related]
20. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line.
Huang M; Liu G
Cancer Lett; 1999 Jan; 135(1):97-105. PubMed ID: 10077227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
